These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 35734636

  • 21. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB.
    Menopause; 2007; 14(3 Pt 1):373-84. PubMed ID: 17438515
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Correlation between plasma sphingosine-1-phosphate and the occurrence and severity of coronary heart disease in postmenopausal women.
    Deng S, Ao Z, Liu B, She Q, Du J, Liu Y, Jing X.
    Menopause; 2022 Aug 01; 29(8):920-925. PubMed ID: 35881936
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23.
    Linzmeier RM, Ganz T.
    Genomics; 2005 Oct 01; 86(4):423-30. PubMed ID: 16039093
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.
    JAMA; 2000 Apr 12; 283(14):1845-52. PubMed ID: 10770146
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Interleukin‑37 is increased in peripheral blood mononuclear cells of coronary heart disease patients and inhibits the inflammatory reaction.
    Li H, Shen C, Chen B, Du J, Peng B, Wang W, Chi F, Dong X, Huang Z, Yang C.
    Mol Med Rep; 2020 Jan 12; 21(1):151-160. PubMed ID: 31746393
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.
    Col NF, Pauker SG, Goldberg RJ, Eckman MH, Orr RK, Ross EM, Wong JB.
    Arch Intern Med; 1999 Jul 12; 159(13):1458-66. PubMed ID: 10399897
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study.
    Hsia J, Simon JA, Lin F, Applegate WB, Vogt MT, Hunninghake D, Carr M.
    Circulation; 2000 Oct 31; 102(18):2228-32. PubMed ID: 11056097
    [Abstract] [Full Text] [Related]

  • 37. The interplay of long noncoding RNA HULC with microRNA-128-3p and their correlations with lipid level, stenosis degree, inflammatory cytokines, and cell adhesion molecules in coronary heart disease patients.
    Zhu X, Hu J, Xie L.
    Ir J Med Sci; 2022 Dec 31; 191(6):2597-2603. PubMed ID: 35088229
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
    Herrington DM, Fong J, Sempos CT, Black DM, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK.
    Am Heart J; 1998 Jul 31; 136(1):115-24. PubMed ID: 9665228
    [Abstract] [Full Text] [Related]

  • 39. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM.
    JAMA; 2002 Aug 28; 288(8):980-7. PubMed ID: 12190368
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA-34a in coronary heart disease: Correlation with disease risk, blood lipid, stenosis degree, inflammatory cytokines, and cell adhesion molecules.
    Li H, Chen M, Feng Q, Zhu L, Bai Z, Wang B, Guo Z, Hou A, Li H.
    J Clin Lab Anal; 2022 Jan 28; 36(1):e24138. PubMed ID: 34861059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.